...
首页> 外文期刊>Frontiers in Pharmacology >Streptomyces sp. MUM212 as a Source of Antioxidants with Radical Scavenging and Metal Chelating Properties
【24h】

Streptomyces sp. MUM212 as a Source of Antioxidants with Radical Scavenging and Metal Chelating Properties

机译:链霉菌 sp。 MUM212作为具有自由基清除和金属螯合特性的抗氧化剂来源

获取原文
           

摘要

Reactive oxygen species and other radicals potentially cause oxidative damage to proteins, lipids, and DNA which may ultimately lead to various complications including mutations, carcinogenesis, neurodegeneration, cardiovascular disease, aging, and inflammatory disease. Recent reports demonstrate that Streptomyces bacteria produce metabolites with potent antioxidant activity that may be developed into therapeutic drugs to combat oxidative stress. This study shows that Streptomyces sp. MUM212 which was isolated from mangrove soil in Kuala Selangor, Malaysia, could be a potential source of antioxidants. Strain MUM212 was characterized and determined as belonging to the genus Streptomyces using 16S rRNA gene phylogenetic analysis. The MUM212 extract demonstrated significant antioxidant activity through DPPH, ABTS and superoxide radical scavenging assays and also metal-chelating activity of 22.03 ± 3.01%, 61.52 ± 3.13%, 37.47 ± 1.79%, and 41.98 ± 0.73% at 4 mg/mL, respectively. Moreover, MUM212 extract was demonstrated to inhibit lipid peroxidation up to 16.72 ± 2.64% at 4 mg/mL and restore survival of Vero cells from H_(2)O_(2)-induced oxidative damages. The antioxidant activities from the MUM212 extract correlated well with its total phenolic contents; and this in turn was in keeping with the gas chromatography–mass spectrometry analysis which revealed the presence of phenolic compounds that could be responsible for the antioxidant properties of the extract. Other chemical constituents detected included hydrocarbons, alcohols and cyclic dipeptides which may have contributed to the overall antioxidant capacity of MUM212 extract. As a whole, strain MUM212 seems to have potential as a promising source of novel molecules for future development of antioxidative therapeutic agents against oxidative stress-related diseases.
机译:活性氧和其他自由基可能对蛋白质,脂质和DNA造成氧化损伤,最终可能导致各种并发症,包括突变,致癌作用,神经变性,心血管疾病,衰老和炎性疾病。最近的报道表明,链霉菌细菌产生具有强抗氧化活性的代谢产物,可能会发展成为对抗氧化应激的治疗药物。这项研究表明链霉菌属。从马来西亚瓜拉雪兰莪的红树林土壤中分离出来的MUM212可能是抗氧化剂的潜在来源。使用16S rRNA基因系统发育分析,将菌株MUM212鉴定为链霉菌属。 MUM212提取物通过DPPH,ABTS和超氧化物自由基清除试验显示出显着的抗氧化活性,并且在4 mg / mL时的金属螯合活性分别为22.03±3.01%,61.52±3.13%,37.47±1.79%和41.98±0.73% 。此外,已证明MUM212提取物在4 mg / mL时抑制脂质过氧化高达16.72±2.64%,并能从H_(2)O_(2)诱导的氧化损伤中恢复Vero细胞的存活。 MUM212提取物的抗氧化活性与其总酚含量密切相关。反过来,这与气相色谱-质谱分析相吻合,该分析表明酚类化合物的存在可能与提取物的抗氧化性能有关。检测到的其他化学成分包括碳氢化合物,醇和环状二肽,它们可能对MUM212提取物的总体抗氧化能力有贡献。总体而言,菌株MUM212似乎具有潜在的新型分子来源,可用于未来开发抗氧化应激相关疾病的抗氧化治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号